Organ Donors with Malignant Gliomas: An Update

American Journal of Transplantation

Volumn 4, Issue 1, 2004, Pages 15-21

  Collignon, Federic P ^a   Holland, Eric C ^a   Feng, Sandy ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CNS tumor; Glioma; Malignancy; Organ donor; Tumor transmission

Indexed keywords

CANCER CLASSIFICATION; CANCER GRAFT; CANCER RISK; CANCER TRANSPLANTATION; CENTRAL NERVOUS SYSTEM TUMOR; CLINICAL FEATURE; DECISION MAKING; DYING; GLIOBLASTOMA; HISTOLOGY; HUMAN; MEDICAL ETHICS; ORGAN DONOR; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; SHORT SURVEY; TERMINAL CARE; UNITED STATES;

BRAIN NEOPLASMS; CENTRAL NERVOUS SYSTEM NEOPLASMS; ETHICS; GLIOMA; HUMANS; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; ORGAN TRANSPLANTATION; RISK; SIGNAL TRANSDUCTION; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS;

EID: 0742301291     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1600-6143.2003.00289.x     Document Type: Short Survey

References (28)

1. Kleihues P, Burger PC, Scheithauer BW. The new WHO classification of brain tumors. Brain Pathol 1993; 3: 255-68. Review.
2. Fecteau AH, Penn I, Hanto DW. Peritoneal metastasis of intracranial glioblastoma via a ventriculoperitoneal shunt preventing organ retrieval. Case report and review of the literature. Clin Transplant 1998; 12: 348-350. Review.
3. Healey PJ, Davis C. Transmission of tumours by transplantation. Lancet 1998; 4: 2-3.
4. Hoffman HJ, Duffner PK. Extraneural metastases of central nervous system tumors. Cancer 1985; 56: 1778-1782.
5. Bosmans JL, Ysebaert D, De Cock AM et al. Interferon-alpha and the cure of metastasis of a malignant meningioma in a kidney allograft recipient: a case report. Transplant Proc 1997; 29: 838.
6. Colquhoun SE, Robert ME, Shaked A et al. Transmission of CNS malignancy by organ transplantation. Tranplantation 1994; 57: 970-974.
7. Frank S, Muller J, Bonk C, Haroske G, Schackert HK, Schackert G. Transmission of glioblastoma multiforme through liver transplantation. Lancet 1998; 352: 31.
8. Jonas S, Bechstein WO, Lemmens HP, Neuhaus R, Thalmann U, Neuhaus P. Liver graft-transmitted glioblastoma multiforme. A case report and experience with 13 multiorgan donors suffering from primary cerebral neoplasia. Transplant Int 1996; 9: 426-429.
9. Lefrancois N, Touraine JL, Cantarovich D et al. Transmission of medulloblastoma from cadaver donor to three organ transplant recipients. Transplant Proc 1987; 19: 2242.
10. Morse JH, Turcotte JG, Merion RM, Campbell DA, Burtch GD, Lucey MR. Development of a malignant tumor in a liver transplant graft procured from a donor with a cerebral neoplasm. Transplantation 1990; 50: 875-877.
11. Ruiz JC, Cotorruelo JG, Tudela V et al. Transmission of glioblastoma multiforme to two kidney transplant recipients from the same donor in the absence of ventricular shunt. Tranplantation 1993; 55: 682-683.
12. Val-Bernal F, Ruiz JC, Cotorruelo JG, Arias M. Glioblastoma multiforme of donor origin after renal transplantation: report of a case. Hum Pathol 1993; 24: 1256-1259.
13. Kauffman HM, McBride MA, Cherikh WS, Spain PC, Delmonico FL. Transplant tumor registry: donors with central nervous system tumors. Tranplantation 2002; 73: 579-582.
14. Chui AK, Herbertt K, Wang LS et al. Risk of tumor transmission in transplantation from donors with primary brain tumors: an Australian and New Zealand registry report. Transplant Proc 1999; 31: 1266-1267.
15. Penn I. Transmission of cancer from organ donors. Ann Transplant 1997; 2: 14-17.
16. Boring CC, Squires ST, Tong T, Montgomery S. Cancer statistics 1994. Ca Cancer J Clinic 1994; 44: 7-26.
17. Velema JP, Percy CL. Age curves of central nervous system incidence in adults: variation of shape by histologic type. J Natl Cancer Institute 1987; 79: 623-629.
18. Pollack I. Brain tumors in children. N Engl J Med 1994; 331: 1500-1507.
19. Kelly PJ, Daumas-Duport C, Kispert DB, Kall BA, Scheithauer BW, Illig JJ. Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. J Neurosurg 1987; 66: 865-874.
20. Davis FG, McCarthy BJ, Berger MS. Centralized database available for describing primary brain tumor incidence, survival, and treatment: Central Brain Tumor Registry of the United Sates; Surveillance, Epidemiology, and End Results; and National Cancer Data Base. Neuro-oncol 1999; 1: 205-211.
21. Dai C, Celestino JC, Okada Y, Louis DN, Fuller GN, Holland EC. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo. Genes Dev 2001; 15: 1913-1925.
22. Guha A, Fedkamp MM, Lau N, Boss G, Pawson A. Proliferation of human malignant astrocytomas is dependent on Ras activation. Oncogene 1997; 15: 2755-2765.
23. Holland EC. Gliomagenesis. Genetic alterations and mouse models. Nat Rev Genet 2001; 2: 120-129.
24. Pasquier B, Pasquier D, N'Golet A, Panh MH, Couderc P, Extraneural metastases of astrocytomas and glioblastomas. Clinicopathological study of two cases and review of literature. Cancer 1980; 45: 112-125.
25. Thomas G, Hall MN, TOR signaling and control of cell growth. Curr Opin Cell Biol 1997; 9: 782-787.
26. Davies MA, Lu Y, Sano T et al. Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induce anoikis. Canc Res 1998; 58: 5285-5290.
27. Neshat MS, Mellinghoff IK, Tran C et al. Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR. Proc Natl Acad Sci U S A 2001; 98: 10314-10319.
28. Hojo M, Morimoto T, Maluccio M. Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature 1999; 397: 530-534.